LTBR agonists in anti-cancer combination therapy
The present invention relates to a combination comprising a Treg scavenger and an LTBR agonist. Such combinations are particularly useful in the treatment of cancer. Examples are the production of mouse antagonist CCR8VHH and CCR8VHH-Fc fusions, as well as LTBR agonistic single domain antibodies. An...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!